Table 3.
Treatment with antipsychotic medications in the ICU for suspected delirium.
| n = 665 | |
|---|---|
| APM prescribed | 17% (113/665) |
| Patients who received APMs | |
| After being screened for delirium | 63.7% (72/113) |
| After not being screened for delirium | 36.3% (41/113) |
| Patients who were screened for delirium who received APMs | |
| with a positive CAM-ICU result | 57.3% (43/75) |
| with a negative CAM-ICU result | 9.1% (29/320) |
| Patients that received | |
| one agent | 12.6% (84/665) |
| two agents | 3.5% (23/665) |
| three agents | 0.9% (6/665) |
| Most used APM | |
| Quetiapine | 6% (40/665) |
| Haloperidol | 4.5% (30/665) |
| Olanzepine | 3.3% (22/665) |
| Droperidol | 2.6% (17/665) |
| Risperidone | 0.5% (3/665) |
| Other | 0.2% (1/665) |
| Patients who received non-APM treatment with a benzodiazepine | |
| with a positive CAM-ICU result | 68% (51/75) |
| with a negative CAM-ICU result | 35% (114/320) |
| Patients who received non-APM treatment with an alpha-2 agonist | |
| with a positive CAM-ICU result | 45.3% (34/75) |
| with a negative CAM-ICU result | 13.4% (43/320) |
APMs: antipsychotic medications; CAM-ICU: Confusion Assessment Method for ICU; ICU: Intensive Care Unit.